CHATTERTON JON E has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are FIT BIOTECH OYJ PLC, GENESENSE TECHNOLOGIES INC and ASTELLAS INST FOR REGENERATIVE MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Chatterton Jon E | 12 |
#2 | Clark Abbot F | 7 |
#3 | Wax Martin B | 3 |
#4 | Bingaman David P | 3 |
#5 | Timmers Adrian M | 2 |
#6 | Li Henry | 1 |
#7 | Wong-Staal Flossie | 1 |
#8 | Ke Ning | 1 |
#9 | Fan Wufang | 1 |
Publication | Filing date | Title |
---|---|---|
US2009209627A1 | RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions |